JAGX stock news today

Form S-3 lets the company sell new securities later without a new full registration.

Jaguar Health submits S-3 paperwork and reports clinical trial progress

The company lodged an S-3 document with regulators and shared news about its clinical trial. The filing covers securities registration, and the trial update describes where the study stands.

Form S-3 lets the company sell new securities later without a new full registration.

Jaguar Health files Form S-3 covering $75M of securities

Jaguar Health registered up to $75 million in securities using a Form S-3 shelf registration. This lets the company offer and sell those securities over time.

Jaguar Health unit gives crofelemer via expanded access to congenital sodium diarrhea patient

Napo Pharmaceuticals, part of Jaguar Health, said a congenital sodium diarrhea patient received crofelemer through an expanded-access program. The company also intends to submit a new drug application for the therapy in MVID around mid-2027.

Jaguar Health updates special stock dividend; Nasdaq ex-dividend date October 16

Jaguar Health gave an update on its special stock dividend. Nasdaq set October 16 as the ex-dividend date for the payout.

Jaguar Health Shares Rise Over 34% in After-Hours Trading

Jaguar Health stock gained more than 34% after the regular session ended. The headline gives no stated reason for the move.

Jaguar Health Stock Halted After 54.54% Surge

Trading in Jaguar Health was paused by a circuit breaker as the share price climbed 54.54%. The halt was triggered by the upward move in the stock.

Jaguar Health shares rise after special dividend announcement

Jaguar Health announced a special dividend, and its shares traded higher following the news.

Jaguar Health Sets Preferred Stock Payout for November 2

The company is issuing a preferred stock payout that holders can exchange for five common shares apiece. This comes as the firm weighs strategic alternatives.

Jaguar Health retires 2025 promissory note through debt-for-equity swaps

Jaguar Health completed exchanges that swapped equity for debt, trimming what it owes by over $6.7 million. Its 2025 promissory note is now fully paid off.

Jaguar Health swaps $5.05 million in borrowings for shares

Jaguar Health gave lenders common stock in place of about $5.05 million owed. Issuing those shares raises the total count outstanding, which reduces existing holders' ownership stakes.

What is the latest news on JAGX?

Nov 3, 2026: Jaguar Health, Inc. filed an amended version of a shelf registration for future offerings (Form S-3) (SEC) · Oct 28, 2026: Jaguar Health submits S-3 paperwork and reports clinical trial progress (Fiscal.ai) · Oct 22, 2026: Jaguar Health, Inc. filed a shelf registration for future offerings (Form S-3) (SEC)

What has JAGX filed with the SEC recently?

Nov 3, 2026: Jaguar Health, Inc. filed an amended version of a shelf registration for future offerings (Form S-3) · Oct 22, 2026: Jaguar Health, Inc. filed a shelf registration for future offerings (Form S-3)